Reducing intake of this drug could improve patient outcomes post-stent

A recent study found prolonged aspirin use might be ineffective, and in some cases harmful, to patients with stents.

The study, published Oct. 23 in Circulation, looked at more than 7,500 patients with acute coronary syndrome who were treated with percutaneous coronary intervention. 

They found stopping aspirin intake three months post-procedure did not increase risk of clotting or cardiac complications and significantly reduced the risk of severe bleeding, a possible aspirin side effect, by nearly 50%.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Whitepapers

Featured Webinars